| Investigating the Clinical Aspects of Using CT vs. CT-MRI Images During Organ Delineation and Treatment Planning in Prostate Cancer Radiotherapy. | |
| | |
MedLine Citation:
|
PMID: 21517129 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
In order to apply highly conformal dose distributions, which are characterized by steep dose fall-offs, it is necessary to know the exact target location and extension. This study aims at evaluating the impact of using combined CT-MRI images in organ delineation compared to using CT images alone, on the clinical results. For 10 prostate cancer patients, the respective CT and MRI images at treatment position were acquired. The CTV was delineated using the CT and MRI images, separately, whereas bladder and rectum were delineated using the CT images alone. Based on the CT and MRI images, two CTVs were produced for each patient. The mutual information algorithm was used in the fusion of the two image sets. In this way, the structures drawn on the MRI images were transferred to the CT images in order to produce the treatment plans. For each set of structures of each patient, IMRT and 3D-CRT treatment plans were produced. The individual treatment plans were compared using the biologically effective uniform dose () and the complication-free tumor control probability (P(+)) concepts together with the DVHs of the targets and organs at risk and common dosimetric criteria. For the IMRT treatment, at the optimum dose level of the average CT and CT-MRI delineated CTV dose distributions, the P(+) values are 74.7% in both cases for a of 91.5 Gy and 92.1 Gy, respectively. The respective average total control probabilities, PB are 90.0% and 90.2%, whereas the corresponding average total complication probabilities, P(I) are 15.3% and 15.4%. Similarly, for the 3D-CRT treatment, the average P(+) values are 42.5% and 46.7%, respectively for a of 86.4 Gy and 86.7 Gy, respectively. The respective average P(B) values are 80.0% and 80.6%, whereas the corresponding average P(I) values are 37.4% and 33.8%, respectively. For both radiation modalities, the improvement mainly stems from the better sparing of rectum. According to these results, the expected clinical effectiveness of IMRT can be increased by a maximum ΔP(+) of around 0.9%, whereas of 3D-CRT by about 4.2% when combined CT-MRI delineation is performed instead of using CT images alone. It is apparent that in both IMRT and 3D-CRT radiation modalities, the better knowledge of the CTV extension improved the produced dose distribution. It is shown that the CTV is irradiated more effectively, while the complication probabilities of bladder and rectum, which is the principal organs at risk, are lower in the CT-MRI based treatment plans. |
| | |
Authors:
|
A Tzikas; P Karaiskos; N Papanikolaou; P Sandilos; E Koutsouveli; E Lavdas; C Scarleas; K Dardoufas; B K Lind; P Mavroidis |
Related Documents
:
|
1373669 - Computed tomography of sclerosing hepatocellular carcinoma. 8553949 - Hepatic tumors treated by cryosurgery: normal ct appearance. 7613949 - Computed tomographic portography in preoperative imaging of hepatic neoplasms. 21542959 - Clinical applications of 18f-fluorodeoxyglucose positron emission tomography/computed t... 17632749 - Triphasic dynamic ct findings of 63 hepatic focal nodular hyperplasia in 46 patients: c... 10518309 - Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. 19166239 - Multimodality image guided total marrow irradiation and verification of the dose delive... 22532859 - Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the earl... 503499 - The ct scan: pitfalls and posterior fossa cisternography. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Technology in cancer research & treatment Volume: 10 ISSN: 1533-0338 ISO Abbreviation: Technol. Cancer Res. Treat. Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-04-26 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101140941 Medline TA: Technol Cancer Res Treat Country: United States |
Other Details:
|
Languages: eng Pagination: 231-42 Citation Subset: IM |
Affiliation:
|
Department of Medical Radiation Physics, Karolinska Institutet and Stockholm University, Sweden. panayiotis.mavroidis@ki.se. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Dosimetric and Delivery Advantages of a New 160-leaf MLC.
Next Document: Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation th...